(Allergan plc)

	AGN latest price $298.3611 (-1.85%) ($298.1584 - $305.8894) on Tue. Mar. 24, 2015.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.43% (three month average)
RSI	62
Latest Price	$298.3611(-1.85%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN advances 0.1% a day on average for past five trading days.
Weekly Trend	AGN advances 3.7% a week on average for past two weeks.
Market Behavior	Value stocks sell-off for large cap. Normal for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   XLV(55%)    IBB(54%)    XBI(47%)    SPY(43%)    QQQ(42%)
Factors Impacting AGN price	AGN will decline at least -0.715% in a week (0% probabilities).   VIXM(-31%)    TLT(-18%)    SHY(-7%)    UUP(-5%)    IGOV(-5%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.715% (StdDev 1.43%)
Hourly BBV	0 ()
Intraday Trend	-2.1%

5 Day Moving Average	$302.97(-1.52%)
10 Day Moving Average	$296.95(0.48%)
20 Day Moving Average	$290.06(2.86%)
To recent high	-2.5%
To recent low	21.6%
Market Cap	$98.37b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed